Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Report on hematopoietic cell transplantations performed in 2018/2019 focusing on the trends of selection of stem cell sources in the Asia-Pacific region: APBMT Activity Survey.
Blood Cell Ther
November 2023
Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT), Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
The number of hematopoietic stem cell transplantations (HCTs) is increasing annually worldwide, and the Asia-Pacific (AP) region is no exception. We report on the absolute number of HCTs in 2018 and 2019 and the trends in graft selection and disease indication in the past few decades. In 2018, 24,292 HCTs were performed in the AP region, of which 8,754 (36.
View Article and Find Full Text PDFPort implantation-related bloodstream infection caused by : A case report.
Curr Med Mycol
March 2023
Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background And Purpose: is a new opportunistic yeast previously named , which belongs to the order Saccharomycetales. Since its discovery, one environmental isolate of has been reported from Myanmar, and one clinical sample from Iran.
Case Report: We report a case of bloodstream infection related to an implantable venous access port.
Article Synopsis
- The Asia-Pacific Blood and Marrow Transplantation Group (APBMT) has been surveying hematopoietic stem cell transplant activities annually since 2007, collecting data from 21,504 transplants in 2017 across 733 centers in 20 countries/regions.
- Five countries—China, Japan, South Korea, India, and Australia—accounted for 89.4% of transplants, with Japan and China also hosting the majority of transplant centers.
- The study revealed significant variations in transplant types between countries, with autologous transplants more common in some regions like Thailand and Australia, while allogeneic transplants dominated in others like Pakistan and China; acute myeloid leukemia was the
Haematological profile of malaria patients with G6PD and PKLR variants (erythrocytic enzymopathies): a cross-sectional study in Thailand.
Malar J
August 2022
Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, 1873 Rama 4 Rd., Pathumwan, Bangkok, 10330, Thailand.
Background: Glucose 6-phosphate dehydrogenase (G6PD) and pyruvate kinase (PKLR) deficiencies are common causes of erythrocyte haemolysis in the presence of antimalarial drugs such as primaquine and tafenoquine. The present study aimed to elucidate such an association by thoroughly investigating the haematological indices in malaria patients with G6PD and PKLR variants.
Methods: Blood samples from 255 malaria patients from Thailand, Myanmar, Laos, and Cambodia were collected to determine haematological profile, G6PD enzyme activity and G6PD deficiency variants.
Clinical Severity of β-Thalassemia Pediatric Patients in Myanmar.
Hemoglobin
January 2022
Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
β-Thalassemia (β-thal) is highly prevalent in Myanmar, but limited data are available on the molecular basis and the clinical manifestations in Myanmar patients. In this study, we investigated the clinical features and β-globin gene abnormalities in 15 homozygous β-thal and 60 Hb E (: c.79G>A)/β-thal pediatric patients who attended Yangon Children Hospital, the biggest thalassemia day care unit center in Myanmar.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!